⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AXSM News
Axsome Therapeutics, Inc
Verismo Therapeutics Presents Preclinical Data at AACR 2026 for SynKIR™-310 KIR-CAR Indicating Superior Preclinical Activity in B Cell Malignancies and Early Clinical Efficacy
prnewswire.com
AXSM
Space Foundation Premieres National Space Day Video May 1
globenewswire.com
AIR
AXSM
VOYG
Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4
globenewswire.com
AXSM
Centri Announces Panel Topics and Featured Programming for Second Annual Capital Conference at Nasdaq on April 14
accessnewswire.com
NDAQ
DFIN
PTGX
STRL
TNDM
AXSM
CSTL
CYTK
GILD
INSM
KODK
NBIX
OCGN
REGN
SRPT
VRTX
XBIT
AMZN
GOOGL
MSFT
NVDA
IBM
ORGN
BWEN
CCJ
EXC
NEE
SO
UTL
XOM
BALY
OXY
PBF
CHRD
AX
BAC
MAXN
PHIO
KZR
SMX
DUOT
COIN
EHTH
Form 8-K
sec.gov
AXSM
Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions
globenewswire.com
AXSM
Form 8-K
sec.gov
FBIO
FBIOP
AXSM
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Atkore Inc. (ATKR), Axsome Therapeutics, Inc. (AXSM), Capricor Therapeutics, Inc. (CAPR), and CTO Realty Growth, Inc. (CTO)
globenewswire.com
ATKR
AXSM
CAPR
CTO
Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders
prnewswire.com
HELP
AXSM
RLMD
ANRO
CMPS
Axsome Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
AXSM